About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: LGS

Clobazam in Lennox-Gastaut syndrome: phase III results

August 29, 2012

Browse by Topic

MS (269)
AD (81)
PD (77)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)
SCHIZOPHRENIA (25)

STROKE (22)
EPILEPSY (21)
COVID-19 (17)
ECTRIMS 2015 (13)
AAN 2015 (11)
ECTRIMS 2014 (10)
DEMENTIA (10)
ECTRIMS 2018 (10)
ECTRIMS 2019 (10)
ECTRIMS 2013 (9)
AAN 2014 (9)
MS SEQUENCING (9)
AAN 2013 (9)
PSYCHIATRY (8)
AAN 2019 (7)
ACTRIMS-ECTRIMS 2020 (7)
ECTRIMS 2017 (7)
ECTRIMS 2016 (6)
CHARCOT 2013 (6)
CCSVI (5)
BIPOLAR (5)
ANXIETY (5)
AAN 2017 (4)
EAN 2015 (4)
BPD (4)
NeuroSound (4)
AAN 2018 (3)
PAIN (3)
ENS 2013 (3)
AAN 2020 (3)
APA 2014 (2)
EAN 2020 (2)
SPECIAL REPORT (2)
SLEEP (2)
NEW DRUGS (2)
AAN 2016 (2)
ADDICTION (1)
EAN 2019 (1)
LUMBAR PUNCTURE (1)
CONCUSSION (1)
CIDP (1)
Dravet syndrome (1)
hATTR (1)
ALS (1)
SEIZURE (1)
INSOMNIA (1)
WEST NILE (1)
LGS (1)
APA 2016 (1)
EAN 2016 (1)
GUIDELINES (1)
TSC (1)
ECTRIMS 2020 (0)

View all Topics

Popular Posts

COVID vaccine guidance for MS patients posted on January 22, 2021
Multiple sclerosis 2021 – a look ahead posted on January 13, 2021
Progression independent of relapses (PIRA) in MS posted on November 21, 2019

Copyright 2021 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions